Quantcast

Latest Pefloxacin Stories

2014-09-16 08:30:15

Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc. (SPI), a research-stage biopharmaceutical company developing novel orally active drugs that restore or increase the effectiveness of existing antibiotics, announced today a $1.4 million convertible debt financing. Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc.,...

2014-05-23 12:24:30

A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON, May 23, 2014 /PRNewswire-USNewswire/ -- A group of 50 Americans who call themselves "Floxies" because they each took the prescribed antibiotic medication Fluoroquinolone which they allege has had disastrous health consequences, have appealed to members of Congress for help in warning others. In their...

2014-05-08 08:32:32

SAN DIEGO, May 8, 2014 /PRNewswire/ -- Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment has been completed in its pivotal studies of AuriPro(TM) (previously known as OTO-201) for the treatment of pediatric patients with bilateral middle ear effusion requiring tympanostomy tube placement. http://photos.prnewswire.com/prnvar/20130806/MM59802LOGO The two...

2014-02-20 23:23:30

Drug Allegedly Linked to Serious Muscle Problems and Nerve Damage Dallas, TX (PRWEB) February 20, 2014 The national law firm of Baron and Budd is now representing clients filing lawsuits against the maker of Cipro, an antibiotic that has been allegedly linked to nerve damage and peripheral neuropathy. This is a muscle condition that can lead to several problems, including difficulty walking, significant pain and arm and leg numbness. Cipro, the brand name for the drug ciprofloxacin, is...

2014-02-05 12:28:03

Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed enrollment in three phase 3 safety studies of ETI-204, an anti-toxin in development for the treatment of inhalational anthrax. Elusys also announced it has completed enrollment in an additional study to evaluate the tolerability...

2013-11-27 15:08:04

In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) and an increased risk of retinal detachment, according to a study appearing in the November 27 issue of JAMA. Retinal detachment (a separation of the retina from its connection at the back of the eye) is an acute eye disorder that may lead to loss of vision despite prompt surgical intervention. A recent study...

2013-10-11 23:25:47

The United States Food and Drug Administration (FDA) has recently issued a Drug Safety Announcement and approved a Black Box Warning, one of the harshest warnings, for Pfizer’s antibiotic intravenous (IV) drug Tygacil®. In particular, the FDA warns prescribing doctors and consumers that use of the IV drug Tygacil® is associated with an increased risk of death in comparison to other antibiotic drugs and that the IV antibiotic Tygacil® should only be used in situations where...

2013-08-29 23:30:41

Media health report cites problems with prescribing of antibiotics such as Zithromax by physicians. Resource4thePeople announces it will continue to provide free legal consultations about rights to legal compensation over allegations of dangerous side effects from the use of Zithromax and Zmax SR. San Diego, CA (PRWEB) August 29, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html Resource4thePeople announced today its latest update for consumers keeping abreast...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'